These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17627106)

  • 1. Plasma C-reactive protein and 5-lipoxygenase-activating protein gene promoter poly-A polymorphism in patients with coronary artery disease.
    Jeng JR
    Cardiology; 2008; 109(1):25-32. PubMed ID: 17627106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human C-reactive protein (CRP) gene 1059G>C polymorphism is associated with plasma CRP concentration in patients receiving coronary angiography.
    Dai DF; Chiang FT; Lin JL; Huang LY; Chen CL; Chang CJ; Lai LP; Hsu KL; Tseng CD; Tseng YZ; Hwang JJ
    J Formos Med Assoc; 2007 May; 106(5):347-54. PubMed ID: 17561469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMOX1 gene promoter polymorphism is not associated with coronary artery disease in Koreans.
    Han SW; Song W; Kim HS; Shin KS; Kang H; Cho HC; Ki CS; Park MJ
    Ann Lab Med; 2014 Sep; 34(5):337-44. PubMed ID: 25187885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population.
    Sayers I; Barton S; Rorke S; Sawyer J; Peng Q; Beghé B; Ye S; Keith T; Clough JB; Holloway JW; Sampson AP; Holgate ST
    Clin Exp Allergy; 2003 Aug; 33(8):1103-10. PubMed ID: 12911785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease.
    Taniguchi H; Momiyama Y; Ohmori R; Yonemura A; Yamashita T; Tamai S; Nakamura H; Ohsuzu F
    Atherosclerosis; 2005 Jan; 178(1):173-7. PubMed ID: 15585215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of plasma high sensitive C-reactive protein in detecting three-vessel coronary artery disease: modification by apolipoprotein E genotype.
    Mennander A; Kuukasjärvi P; Laurikka J; Nikus K; Karhunen PJ; Tarkka M; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(8):714-9. PubMed ID: 18609102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease.
    Pasalić D; Marinković N; Grsković B; Ferencak G; Bernat R; Stavljenić-Rukavina A
    Mol Biol Rep; 2009 Apr; 36(4):775-80. PubMed ID: 18401567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease.
    Memon L; Spasojević-Kalimanovska V; Bogavac-Stanojević N; Kalimanovska-Ostrić D; Jelić-Ivanović Z; Spasić S; Topić A
    Tohoku J Exp Med; 2006 Jul; 209(3):197-206. PubMed ID: 16778366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease.
    Assimes TL; Knowles JW; Priest JR; Basu A; Volcik KA; Southwick A; Tabor HK; Hartiala J; Allayee H; Grove ML; Tabibiazar R; Sidney S; Fortmann SP; Go A; Hlatky M; Iribarren C; Boerwinkle E; Myers R; Risch N; Quertermous T
    Hum Genet; 2008 May; 123(4):399-408. PubMed ID: 18369664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.
    Tsai AK; Li N; Hanson NQ; Tsai MY; Tang W
    Atherosclerosis; 2009 Dec; 207(2):487-91. PubMed ID: 19596330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population.
    Xu Y; Wang W; Zhang L; Qi LP; Li LY; Chen LF; Fang Q; Dang AM; Yan XW
    Atherosclerosis; 2011 Dec; 219(2):648-54. PubMed ID: 21722899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
    Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM
    Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of polymorphism in IL-6 gene promoter with BMI, inflammatory factors, and pathogenesis and progression of CHD].
    Jia XW; Tian YP; Wang Y; Deng XX; Dong ZN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1270-5. PubMed ID: 18088482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic variant near adaptor-related protein complex 2 alpha 2 subunit gene is associated with coronary artery disease in a Chinese population.
    Wang S; Ma Z; Zhang Y; Ding Y; Chen Z; Wang L
    BMC Cardiovasc Disord; 2018 Aug; 18(1):161. PubMed ID: 30086706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study.
    Girelli D; Martinelli N; Trabetti E; Olivieri O; Cavallari U; Malerba G; Busti F; Friso S; Pizzolo F; Pignatti PF; Corrocher R
    Eur J Hum Genet; 2007 Sep; 15(9):959-66. PubMed ID: 17505527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
    Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
    Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intron polymorphism in the CXCL16 gene is associated with increased risk of coronary artery disease in Chinese Han population: a large angiography-based study.
    Huang M; Han Y; Zhang X; Pei F; Deng J; Kang J; Yan C
    Atherosclerosis; 2010 May; 210(1):160-5. PubMed ID: 19954776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
    Hakonarson H; Thorvaldsson S; Helgadottir A; Gudbjartsson D; Zink F; Andresdottir M; Manolescu A; Arnar DO; Andersen K; Sigurdsson A; Thorgeirsson G; Jonsson A; Agnarsson U; Bjornsdottir H; Gottskalksson G; Einarsson A; Gudmundsdottir H; Adalsteinsdottir AE; Gudmundsson K; Kristjansson K; Hardarson T; Kristinsson A; Topol EJ; Gulcher J; Kong A; Gurney M; Thorgeirsson G; Stefansson K
    JAMA; 2005 May; 293(18):2245-56. PubMed ID: 15886380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Hs-CRP levels and interleukin 18 (-137G/C) promoter polymorphism in risk prediction of coronary artery disease in first degree relatives.
    G RK; K MS; G KK; Kurapati M; M S; T MA; P C; G SR; S N; P K; K SS; H SR
    PLoS One; 2015; 10(3):e0120359. PubMed ID: 25822970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.